Balance Sheet: Assets
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Statement of Comprehensive Income
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Common Stock Valuation Ratios
- Selected Financial Data since 2005
- Net Profit Margin since 2005
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Vertex Pharmaceuticals Inc., consolidated balance sheet: assets (quarterly data)
US$ in thousands
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
Over the observed period, the company’s total assets exhibited a general upward trend, although with notable fluctuations, particularly in the most recent periods. A significant increase in total assets is apparent between 2021 and 2023, followed by a decrease in early 2024, and a subsequent recovery towards the end of the period. The composition of these assets has also shifted, with varying trends observed across different asset categories.
- Cash and Cash Equivalents
- Cash and cash equivalents demonstrated substantial growth from March 2021 to December 2022, peaking at US$10.504 billion. However, a significant decline occurred in the first half of 2024, falling to US$4.580 billion, before stabilizing and showing modest increases in subsequent quarters. This suggests a potential deployment of cash reserves into other investments or operational activities.
- Marketable Securities
- Marketable securities generally decreased from June 2022 to December 2022, before experiencing a substantial increase in March 2023, reaching US$1.124 billion. This trend continued through December 2024, peaking at US$1.546 billion, and remained relatively high through June 2025. This indicates a strategic shift towards increasing investments in marketable securities.
- Accounts Receivable, Net
- Accounts receivable, net, consistently increased throughout the period, rising from US$977.551 million in March 2021 to US$2.052.8 million in September 2025. This steady growth suggests increasing sales and potentially evolving credit terms.
- Inventories
- Inventories exhibited a consistent upward trend from March 2021 to December 2024, increasing from US$298.863 million to US$1.205.4 million. This substantial increase could be attributed to increased production, anticipated demand, or potential supply chain considerations. The rate of increase slowed in the latter part of the period.
- Prepaid Expenses and Other Current Assets
- This category showed considerable volatility. It increased significantly between March and June 2021, then decreased before rising again to US$726.9 million in September 2022. It then fluctuated, reaching US$853.3 million in December 2025.
- Long-Term Assets
- Long-term assets, encompassing property and equipment, goodwill, intangible assets, deferred tax assets, operating lease assets, and other assets, demonstrated a consistent upward trend overall. Goodwill remained relatively stable until September 2021, then increased slightly. Deferred tax assets and operating lease assets experienced significant growth, particularly in the later periods, contributing substantially to the overall increase in long-term assets. The increase in operating lease assets was particularly pronounced from June 2024 onwards.
In summary, the asset base of the company has expanded considerably over the analyzed timeframe. The shifts in the composition of assets, particularly the fluctuations in cash and cash equivalents alongside the growth in marketable securities, inventories, and long-term assets, suggest active financial management and strategic investment decisions. The consistent growth in accounts receivable indicates a healthy sales trend, while the increase in inventories warrants further investigation to determine the underlying drivers.